Chemoinformaics analysis of 8,9-Dehydrothymyl 2-methylbutyrate
| Molecular Weight | 232.323 | nRot | 4 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 8 |
| Exact Molecular Weight | 232.146 | nRing | 1 |
| Solubility: LogS | -5.141 | nHRing | 0 |
| Solubility: LogP | 4.618 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 39.9899 |
| nHD | 0 | BPOL | 22.6681 |
| QED | 0.579 |
| Synth | 2.739 |
| Natural Product Likeliness | 0.417 |
| NR-PPAR-gamma | 0.015 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.579 |
| MDCK | 0.0000201 |
| BBB | 0.99 |
| PPB | 0.877432 |
| VDSS | 1.049 |
| FU | 0.239879 |
| CYP1A2-inh | 0.958 |
| CYP1A2-sub | 0.848 |
| CYP2c19-inh | 0.903 |
| CYP2c19-sub | 0.684 |
| CYP2c9-inh | 0.804 |
| CYP2c9-sub | 0.698 |
| CYP2d6-inh | 0.071 |
| CYP2d6-sub | 0.678 |
| CYP3a4-inh | 0.561 |
| CYP3a4-sub | 0.445 |
| CL | 11.154 |
| T12 | 0.193 |
| hERG | 0.016 |
| Ames | 0.015 |
| ROA | 0.129 |
| SkinSen | 0.92 |
| Carcinogencity | 0.188 |
| EI | 0.959 |
| Respiratory | 0.69 |
| NR-Aromatase | 0.029 |
| Antiviral | Yes |
| Prediction | 0.794141 |